Created the psoriasis pill Icotyde and a shot for a rare blood cancer.
Bought more
Duquesne owns 208,900 shares of Protagonist Therapeutics, worth about $26 million. That’s less than $1 of every $100 they have in stocks. Between April and June they bought 49,200 more (up 31%).
Mar 31
159,700
Jun 30
208,900
The numbers
Shares they own
208,900
Change since Mar 31
+49,200
+30.8%
Shares on Mar 31
159,700
Value on Jun 30, 2026
$25,607,000
about $26 million
Share of their money
0.6%
less than $1 of every $100 · 32nd of 85
Price per share on Jun 30
$122.58
Cost of the shares they added
about $6 million
at the Jun 30 price
Kind
Shares
Also owned by
No other fund we follow
More about Protagonist Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.